RNXT (STOCKS)
RenovoRx, Inc. Common Stock
$1.030000
+0.044700 (+4.54%)
Prev close: $0.985300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shaun R. Bagai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.95M
- Employees
- 10
- P/E (TTM)
- -3.23
- P/B (TTM)
- 6.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.12M |
| Benefits Costs and Expenses | $12.29M |
| Cost Of Revenue | $327.00K |
| Costs And Expenses | $12.29M |
| Gross Profit | $796.00K |
| Nonoperating Income/Loss | $1.34M |
| Operating Expenses | $13.31M |
| Selling, General, and Administrative Expenses | $7.04M |
| Depreciation and Amortization | $2.00M |
| Research and Development | $6.27M |
| Operating Income/Loss | -$12.51M |
| Income/Loss From Continuing Operations After Tax | -$11.17M |
| Income/Loss From Continuing Operations Before Tax | -$11.17M |
| Income Tax Expense/Benefit | $2.00K |
| Income Tax Expense/Benefit, Current | $2.45M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$11.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.32 |
| Diluted Earnings Per Share | -$0.32 |
| Basic Average Shares | 35,333,127 |
| Diluted Average Shares | 35,333,127 |
| Assets | $8.10M |
| Current Assets | $7.89M |
| Inventory | $189.00K |
| Prepaid Expenses | $324.00K |
| Other Current Assets | $7.38M |
| Noncurrent Assets | $202.00K |
| Fixed Assets | $12.00K |
| Other Non-current Assets | $190.00K |
| Liabilities | $2.67M |
| Current Liabilities | $1.96M |
| Accounts Payable | $799.00K |
| Other Current Liabilities | $1.16M |
| Noncurrent Liabilities | $711.00K |
| Equity | $5.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.42M |
| Liabilities And Equity | $8.10M |
| Net Cash Flow From Operating Activities | -$10.97M |
| Net Cash Flow From Operating Activities, Continuing | -$10.97M |
| Net Cash Flow From Investing Activities | -$2.00K |
| Net Cash Flow From Investing Activities, Continuing | -$2.00K |
| Net Cash Flow From Financing Activities | $10.85M |
| Net Cash Flow From Financing Activities, Continuing | $10.85M |
| Net Cash Flow | -$130.00K |
| Net Cash Flow, Continuing | -$130.00K |
| Comprehensive Income/Loss | -$11.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.17M |
| Other Comprehensive Income/Loss | -$11.17M |